News

AccessClosure Next-Generation Vascular Closure Device ACC.14 March 2014

AccessClosure Inc. commercially launched itsMynx Ace vascular closure device, a safe and secure vascular closure product that provides consistent results with a new, easy-to-use deployment system...

FDA Abbott Supera Self-Expanding Stent Peripheral Artery Disease

The U.S. Food and Drug Administration (FDA) approved Abbott’s Supera Peripheral Stent System to treat people with blocked blood vessels in the upper leg caused by peripheral artery disease (PAD...

March 31, 2014 — BioCardia Inc. announced it received CE mark for its Morph AccessPro steerable introducer, designed for easier navigation through the vasculature during delivery of...

March 31, 2014 — Led by members of the American College of Cardiology (ACC), American Heart Association (AHA) and Society for Cardiovascular Angiography and Interventions (SCAI), 14 professional...

Terumo Corp. Arterial Remodeling Technologies Bioresorbable Coronary Stent

Privately held Arterial Remodeling Technologies (ART) signed a structured buyout agreement with Terumo Corp. Under the agreement, ART and Terumo Corp. will collaborate in the development of a drug...

At the 63rd Annual Scientific Session of the American College of Cardiology (ACC), March 29-31 at the Walter E. Washington Convention Center in Washington, D.C., Siemens Healthcare will deliver...

CBSET Renal Denervation Hypertension Therapies Symplicity-3 Trial

Scientists at CBSET are reminding thought leaders in renal denervation that there is a seminal experimental and computational template for the more rational, comprehensive preclinical evaluation...

Trinias, Shimadzu, angiography systems

The U.S. Food and Drug Administration (FDA) granted 510(k) clearance for three new digital angiography systems...

InspireMD Inc. has enrolled the first patient into the CARENET (CARotid Embolic protection study using microNET) multi-center European...

AccessClosure Mynx Ace Vascular Closure Device Hemostasis Management Cath Lab

AccessClosure plans to launch the Mynx Ace Vascular Closure Device at the 2014 American College of Cardiology meeting, March 29-31. It is an upgrade of the company’s Mynx mechanical ...

Surgeons in France have successfully replaced the aortic valve in two patients without opening the chest during surgery....

PVAD, percutaneous VAD, hemodynamic support, aortix

Percutaneous ventricular assist (pVAD) devices offer more hemodynamic support than the 40-year-old gold standard of intra-aortic balloon pumps (IABPs), but their cost and...

I have watched a trend in medical technology grow from a small ripple a couple years ago into what I expect will be a tidal wave in 2014 due to growing concern over patient radiation dose levels...

Thoratec HeartMate II LVAS Pocket System Controller Heart Failure Devices VAD

Thoratec Corp. initiated a voluntary worldwide Medical Device Correction in order to update its labeling and training materials for the HeartMate II LVAS Pocket System Controller. The following...

The increasing number of percutaneous coronary interventions (PCIs) being performed at low-volume centers without on-site cardiac surgery backup has driven the need for new safety and quality...

Cath Lab Clinical Trial Study Cardiovascular Surgery

National Institutes of Health researchers have identified a biological pathway that contributes to the high rate of vein graft failure following ...

Boston Scientific Rebel Platinum Chromium Coronary Stent System Bare Metal

Boston Scientific Corp. received CE marking for the Rebel Platinum Chromium Coronary Stent System, the company's latest generation ...

Privately held On-X Life Technologies Inc. (On-X LTI) launched its European marketing campaign for the On-X Plus 1.5 Aortic Heart Valve in concert with its Great Britain distributor Vascutek Corp...

Corindus CorPath Robotic Navigation Telemedicine Telecardiology Cath Lab

For patients living in rural areas, life-saving procedures such as an angioplasty may only be available at a facility more than 200 miles away. To bridge this distance, ...

The U.S. Food and Drug Administration (FDA) cleared Cardiovascular Systems Inc.’s Diamondback 360 60 cm Peripheral Orbital Atherectomy Systems (OAS) for the treatment of peripheral arterial...